Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1994-3-17
|
pubmed:abstractText |
Allograft coronary artery disease is a major threat to long-term survival after cardiac transplantation. It has been suggested that hyperlipidemia plays a major role in allograft coronary disease. The objective of the present study was to evaluate the effect of a lipid-lowering intervention with diet and drug therapy after cardiac transplantation. Forty-six patients who underwent transplantation between 1988 and 1991 and who were treated with the American Heart Association phase 1 diet and an HMG coenzyme A reductase inhibitor (lovastatin or simvastatin) when low-density lipoprotein cholesterol levels were higher than 3.4 mmol/L were compared with 35 untreated patients having transplantation between 1983 and 1988. Annual coronary angiograms were obtained in both groups. Cholesterol, triglyceride, and low-density lipoprotein levels were significantly lower in the treated group. Actuarial survival and event-free survival (survival free from allograft coronary artery disease) were similar in both groups. Low-density lipoprotein levels lower than 3 mmol/L at the last follow-up had a positive effect on event-free survival. The cholesterol-lowering intervention was not effective in decreasing the prevalence of allograft coronary artery disease. This study suggests that more aggressive measures to lower low-density lipoprotein levels may be necessary to significantly affect allograft disease. Clinical trials should be developed to address this hypothesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, Dietary,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Lovastatin,
http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0003-4975
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
353-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8311595-Adult,
pubmed-meshheading:8311595-Anticholesteremic Agents,
pubmed-meshheading:8311595-Cholesterol, Dietary,
pubmed-meshheading:8311595-Cholesterol, LDL,
pubmed-meshheading:8311595-Coronary Disease,
pubmed-meshheading:8311595-Female,
pubmed-meshheading:8311595-Heart Transplantation,
pubmed-meshheading:8311595-Humans,
pubmed-meshheading:8311595-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:8311595-Hyperlipidemias,
pubmed-meshheading:8311595-Lovastatin,
pubmed-meshheading:8311595-Male,
pubmed-meshheading:8311595-Middle Aged,
pubmed-meshheading:8311595-Retrospective Studies,
pubmed-meshheading:8311595-Simvastatin,
pubmed-meshheading:8311595-Survival Analysis
|
pubmed:year |
1994
|
pubmed:articleTitle |
Cholesterol-lowering intervention and coronary artery disease after cardiac transplantation.
|
pubmed:affiliation |
Department of Surgery, Montreal Heart Institute, Quebec, Canada.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|